On Thursday 14 May, 2020, Tom Donohue, CEO, U.S. Chamber of Commerce spoke to representatives from AmChams from around the world on a call focused on sharing information on the impact of COVID-19 on businesses. In his remarks, he highlighted the activities of the U.S. Chamber of Commerce aimed at supporting its member companies. Mr Donohue also emphasised the need for governments to work with businesses in order to reopen the economy through practical guidelines and best practices learnt from essential businesses that have remained opened during the crisis.
U.S. Chamber of Commerce CEO speaks to AmChams from around the world on the impact of COVID-19
On Thursday 14 May, 2020, Tom Donohue, CEO, U.S. Chamber of Commerce spoke to representatives from AmChams from around the world on a call focused on sharing information on the impact of COVID-19 on businesses. In his remarks, he highlighted the activities of the U.S. Chamber of Commerce aimed at supporting its member companies. Mr Donohue also emphasised the need for governments to work with businesses in order to reopen the economy through practical guidelines and best practices learnt from essential businesses that have remained opened during the crisis.
Tom Donohue’s remarks were preceded by Myron Brilliant, Executive Vice President and Head of International Affairs, U.S. Chamber of Commerce. He outlined that the U.S. Chamber of Commerce has been monitoring issues like protectionism, export controls and other national economic measures that have increased in the last few months. He also explained that while temporary measures and flexibility to rules are understandable in this context, these should not continue indefinitely as they can jeopardise competition and the market.
The call closed with presentations from Directors of several AmChams around the world such as Germany, Kenya, Malaysia, and Peru among others. During their interventions, the Directors shared their experiences and priorities in dealing with the impact of COVID-19 on their member companies and national economies. Some of the common themes included concerns about the ability of small and medium enterprises to stay afloat, the high unemployment rates, disruption to supply chains and the flow of goods.
Related items
:focal())
News
5 May 2026
Simplifying the Foreign Subsidies Regulation
With the Foreign Subsidies Regulation (FSR) under review, now is the moment to ensure it delivers on its objectives without creating unnecessary complexity. The FSR plays an important role in addressing distortive foreign subsidies. However, its broad scope and resource-intensive procedures risk undermining its effectiveness.
The current framework creates significant burdens for investors and contracting authorities managing public procurement processes. Changes to the Implementing Regulation alone would only provide limited value. Simplification will require targeted amendments to the primary legislation.
Read more about proposed amendments that would help refocus the FSR on high-risk cases and support the EU’s competitiveness goals.
:focal())
News
4 May 2026
Discussing financial services with policymakers in Paris and Strasbourg
From Monday, 27 to Wednesday, 29 April, AmCham EU travelled to Paris, France and the European Parliament in Strasbourg, France for a series of meetings on EU financial services policy developments. The delegation engaged with representatives from French and European financial authorities, Members of the European Parliament, Accredited Parliamentary Assistants and Group Policy Advisers, to share business perspectives on the EU’s financial services agenda. Discussions focused on how to improve Europe’s competitiveness, deepen capital markets and create the right conditions for innovation in digital finance. Members also highlighted the need for more coherent and interoperable rules that reduce complexity while encouraging long-term investment through risk-based regulation.
:focal())
News
4 May 2026
Discussing healthcare policy priorities in Strasbourg
On Tuesday, 28 to Wednesday, 29 April, AmCham EU travelled to the European Parliament in Strasbourg, France for a series of meetings with policymakers to discuss ongoing EU healthcare policy initiatives. The delegation met with Members of the European Parliament, Accredited Parliamentary Assistants and Group Policy Advisers, to discuss priorities for the EU’s health agenda. This included exchanges on how to strengthen Europe’s life sciences competitiveness and support resilient supply chains. Members also stressed the need for urgent action to simplify overlapping rules and reduce complexity. They underlined that proportionate, risk-based regulation is essential to support innovation. This approach can also help ensure timely patient access to medicines, medical technologies and diagnostics.
Policy priorities
Insights and advocacy driving Europe’s policy agenda. Our priorities support growth, innovation and a stronger transatlantic economy.
Membership
Connecting business and policymakers to strengthen the voice of American companies in Europe.